Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Leukemia
Findings from X. Leleu and co-authors broaden understanding of acute leukemia
February 24th, 2009
According to recent research from the United States, " Nucleoside analogs (NAs) are considered as appropriate agents in the treatment of Waldenstrom macroglobulinemia (WM), a lymphoplasmacytic lymphoma. Sporadic reports on increased incidence of transformation to high-grade non-Hodgkin's lymphoma and development of therapy-related myelodysplasia/acute leukemia (t-MDS/AML) among patients with WM treated with NAs prompted us to examine the incidence of such events in a large population of patients with WM." "Patients and Methods We examined the incidence of these events in 439 patients with WM, 193 and 136 of whom were previously treated with and without an NA,...
Source: Cancer Weekly (2009-02-24)
|
